These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 24732864

  • 21. Prevalence of celiac disease and celiac autoimmunity in the Toba Native Amerindian community of Argentina.
    Vázquez H, de la Paz Temprano M, Sugai E, Scacchi SM, Souza C, Cisterna D, Smecuol E, Moreno ML, Longarini G, Mazure R, Bartellini MA, Verdú EF, González A, Mauriño E, Bai J.
    Can J Gastroenterol Hepatol; 2015; 29(8):431-4. PubMed ID: 26207618
    [Abstract] [Full Text] [Related]

  • 22. Transglutaminase IgA antibodies in a celiac disease mass screening and the role of HLA-DQ genotyping and endomysial antibodies in sequential testing.
    Sandström O, Rosén A, Lagerqvist C, Carlsson A, Hernell O, Högberg L, Ivarsson A.
    J Pediatr Gastroenterol Nutr; 2013 Oct; 57(4):472-6. PubMed ID: 23783015
    [Abstract] [Full Text] [Related]

  • 23. Interpretation of serological tests in the diagnosis of celiac disease: Anti-deamidated gliadin peptide antibodies revisited.
    Zucchini L, Giusti D, Gatouillat G, Servettaz A, Tabary T, Barbe C, Pham BN.
    Autoimmunity; 2016 Sep; 49(6):414-420. PubMed ID: 27452003
    [Abstract] [Full Text] [Related]

  • 24. Diagnostic efficacy of the ELISA test for the detection of deamidated anti-gliadin peptide antibodies in the diagnosis and monitoring of celiac disease.
    Tonutti E, Visentini D, Picierno A, Bizzaro N, Villalta D, Tozzoli R, Kodermaz G, Carroccio A, Iacono G, Teresi S, La Chiusa SM, Brusca I.
    J Clin Lab Anal; 2009 Sep; 23(3):165-71. PubMed ID: 19455636
    [Abstract] [Full Text] [Related]

  • 25. Increased prevalence of anti-gliadin IgA-antibodies with aberrant duodenal histopathological findings in patients with IgA-nephropathy and related disorders.
    Almroth G, Axelsson T, Müssener E, Grodzinsky E, Midhagen G, Olcén P.
    Ups J Med Sci; 2006 Sep; 111(3):339-52. PubMed ID: 17578801
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Celiac disease: risk assessment, diagnosis, and monitoring.
    Setty M, Hormaza L, Guandalini S.
    Mol Diagn Ther; 2008 Sep; 12(5):289-98. PubMed ID: 18803427
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Significance of a method for determination of deamidated gliadin peptide in the diagnosis of celiac disease].
    Sabelnikova EA, Parfenov AI, Krums LM, Gudkova RB, Sagynbaeva VE, Bykova SV.
    Ter Arkh; 2014 Sep; 86(2):39-43. PubMed ID: 24772506
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome.
    Wahnschaffe U, Schulzke JD, Zeitz M, Ullrich R.
    Clin Gastroenterol Hepatol; 2007 Jul; 5(7):844-50; quiz 769. PubMed ID: 17553753
    [Abstract] [Full Text] [Related]

  • 34. Serologic markers of untreated celiac disease in Libyan children: antigliadin, antitransglutaminase, antiendomysial, and anticalreticulin antibodies.
    Ashabani A, Errabtea H, Shapan A, Tuckova L, Tlaskalova-Hogenova H.
    J Pediatr Gastroenterol Nutr; 2001 Sep; 33(3):276-82. PubMed ID: 11593122
    [Abstract] [Full Text] [Related]

  • 35. Serum autoantibodies directed against transglutaminase-2 have a low avidity compared with alloantibodies against gliadin in coeliac disease.
    Gelderman KA, Drop AC, Trouw LA, Bontkes HJ, Bouma G, van Hoogstraten IM, von Blomberg BM.
    Clin Exp Immunol; 2014 Jul; 177(1):86-93. PubMed ID: 24666357
    [Abstract] [Full Text] [Related]

  • 36. Celiac Disease-Type Tissue Transglutaminase Autoantibody Deposits in Kidney Biopsies of Patients with IgA Nephropathy.
    Nurmi R, Korponay-Szabó I, Laurila K, Huhtala H, Niemelä O, Mustonen J, Mäkelä S, Kaukinen K, Lindfors K.
    Nutrients; 2021 May 11; 13(5):. PubMed ID: 34064541
    [Abstract] [Full Text] [Related]

  • 37. Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.
    Silvester JA, Kurada S, Szwajcer A, Kelly CP, Leffler DA, Duerksen DR.
    Gastroenterology; 2017 Sep 11; 153(3):689-701.e1. PubMed ID: 28545781
    [Abstract] [Full Text] [Related]

  • 38. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
    Lindfors K, Mäki M, Kaukinen K.
    Autoimmun Rev; 2010 Sep 11; 9(11):744-9. PubMed ID: 20547248
    [Abstract] [Full Text] [Related]

  • 39. Serological tests in gluten sensitivity (nonceliac gluten intolerance).
    Volta U, Tovoli F, Cicola R, Parisi C, Fabbri A, Piscaglia M, Fiorini E, Caio G.
    J Clin Gastroenterol; 2012 Sep 11; 46(8):680-5. PubMed ID: 22138844
    [Abstract] [Full Text] [Related]

  • 40. Extension of the celiac intestinal antibody (CIA) pattern through eight antibody assessments in fecal supernatants from patients with celiac disease.
    Di Tola M, Marino M, Casale R, Di Battista V, Borghini R, Picarelli A.
    Immunobiology; 2016 Jan 11; 221(1):63-9. PubMed ID: 26271834
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.